News & Updates

Avelumab with paclitaxel plus ramucirumab shows promise in esophagogastric adenocarcinoma

27 Jan 2024

Combining the programmed cell death ligand 1 (PDL-1) inhibitor avelumab with paclitaxel plus ramucirumab appears to be efficacious and safe in the second-line treatment of metastatic esophagogastric adenocarcinoma, as shown in the phase II nonrandomized RAP trial.

Avelumab with paclitaxel plus ramucirumab shows promise in esophagogastric adenocarcinoma

27 Jan 2024

Shortened terlipressin therapy after endoscopic haemostasis as effective as 3-day course

20 Jan 2024

In cirrhosis patients with acute variceal bleeding (AVB), treatment with terlipressin for a single day yields similar rebleeding and mortality rates as 3-day treatment following endoscopic haemostasis, while having an overall superior safety profile, according to a study.

Shortened terlipressin therapy after endoscopic haemostasis as effective as 3-day course

20 Jan 2024

Linaclotide improves bowel movement frequency in children with functional constipation

20 Jan 2024 by

Once-daily treatment with linaclotide, a guanylate cyclase C agonist, significantly improved the frequency of spontaneous bowel movements (SBMs) in paediatric patients with functional constipation, according to a recent study.

Linaclotide improves bowel movement frequency in children with functional constipation

20 Jan 2024

Probiotic Bif195 helps protect against aspirin-induced stomach damage

19 Jan 2024 by

The probiotic strain Bifidobacterium breve (Bif195), when co-administered with aspirin, appears to mitigate stomach injury caused by aspirin, according to the results of a randomized crossover trial.

Probiotic Bif195 helps protect against aspirin-induced stomach damage

19 Jan 2024

TaTME-DCAA feasible for low rectal cancer

19 Jan 2024 by

A retrospective, propensity score-matched analysis from Singapore demonstrates the feasibility of transanal total mesorectal excision with delayed coloanal anastomosis (TaTME-DCAA) as a surgical alternative for non-metastatic low rectal cancer.

TaTME-DCAA feasible for low rectal cancer

19 Jan 2024

Linaclotide works well for functional constipation in children

19 Jan 2024

The guanylate cyclase C agonist linaclotide helps increase the frequency of bowel movements in children with functional constipation, according to data from a phase III trial.

Linaclotide works well for functional constipation in children

19 Jan 2024

Oesophageal cancer survivors more prone to late-onset pneumonia

18 Jan 2024 by

Oesophageal cancer survivors are more likely to develop late-onset pneumonia during their clinical course, a study suggests.

Oesophageal cancer survivors more prone to late-onset pneumonia

18 Jan 2024

Whole grains improve gut health, cardiometabolic markers in children

17 Jan 2024 by

Children who regularly consume wholegrain oats and rye (WG) benefit from lower serum low-density lipoprotein (LDL) cholesterol and triacylglycerol, modulated taxa, and higher beneficial metabolites, according to a recent study.

Whole grains improve gut health, cardiometabolic markers in children

17 Jan 2024

Tricyclic antidepressant for IBS worth a try

15 Jan 2024 by

The tricyclic antidepressant amitriptyline, when used at low dose in the second-line treatment setting and titrated according to symptom response and side-effects, is safe and provides relief from symptoms of irritable bowel syndrome (IBS), as shown in the phase III ATLANTIS* trial.

Tricyclic antidepressant for IBS worth a try

15 Jan 2024

Higher ultra-processed food intake ups risk of NAFLD, severe liver disease

15 Jan 2024

People who consume a lot of ultra-processed food (UPF) have a greater risk of developing nonalcoholic fatty liver disease (NAFLD), liver fibrosis, and cirrhosis, as well as severe liver disease and adverse levels of several clinical biomarkers, reveals a study.

Higher ultra-processed food intake ups risk of NAFLD, severe liver disease

15 Jan 2024

News & Updates

Filter by Specialty:

Specialty:

Avelumab with paclitaxel plus ramucirumab shows promise in esophagogastric adenocarcinoma

Avelumab with paclitaxel plus ramucirumab shows promise in esophagogastric adenocarcinoma

Shortened terlipressin therapy after endoscopic haemostasis as effective as 3-day course

Shortened terlipressin therapy after endoscopic haemostasis as effective as 3-day course

Linaclotide improves bowel movement frequency in children with functional constipation

Linaclotide improves bowel movement frequency in children with functional constipation

Probiotic Bif195 helps protect against aspirin-induced stomach damage

Probiotic Bif195 helps protect against aspirin-induced stomach damage

TaTME-DCAA feasible for low rectal cancer

TaTME-DCAA feasible for low rectal cancer

Linaclotide works well for functional constipation in children

Linaclotide works well for functional constipation in children

Oesophageal cancer survivors more prone to late-onset pneumonia

Oesophageal cancer survivors more prone to late-onset pneumonia

Whole grains improve gut health, cardiometabolic markers in children

Whole grains improve gut health, cardiometabolic markers in children

Tricyclic antidepressant for IBS worth a try

Tricyclic antidepressant for IBS worth a try

Higher ultra-processed food intake ups risk of NAFLD, severe liver disease

Higher ultra-processed food intake ups risk of NAFLD, severe liver disease